PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsvasomotor rhinitis
MeSH D012223 - vasomotor rhinitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012220:Rhinitis
$
Success rate
D012223: 
Vasomotor rhinitis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
PadagisAzelastine Azelastine  2014-05-08   
Azelastine, Fluticasone Azelastine Fluticasone  2021-02-18   
Dextromethorphan, Pseudoephedrine, Brompheniramine Brompheniramine Maleate, Pseudoephedrine Dextromethorphan  2014-07-15   
Taro PharmaceuticalDextromethorphan, Pseudoephedrine, Brompheniramine Brompheniramine Maleate, Pseudoephedrine Dextromethorphan  2017-02-27   
MylanAzelastine Astelin  1996-11-01   
Azelastine Astepro 2025-11-22 2008-10-15   
Azelastine, Fluticasone Dymista 2023-06-13 2012-05-01   
Azelastine Optivar  2000-05-22   
PerrigoIbuprofen, Phenylephrine Ibuprofen Phenylephrine  2014-07-03   
GSKIbuprofen, Phenylephrine, Chlorpheniramine Advil  2011-12-21   
Lupin ResearchPhenylephrine, Ketorolac tromethamine Ketorolac Tromethamine Phenylephrine  2019-07-01   
SandozAzelastine Azelastine  2012-05-31   
Phenylephrine Phenylephrine  2019-01-31   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
67%
8/12
Approved: 7Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use